UBS O'Connor’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-200,000
Closed -$1.94M 1084
2021
Q1
$1.94M Buy
+200,000
New +$1.93M 0.03% 481

Other funds holding ISLE

UBS O'Connor's ISLE Position: Q2 2021 in Review

UBS O'Connor sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q2 2021, closing a stake of 200,000 shares — an estimated $1.94M sold.

UBS O'Connor first reported a position in ISLE in Q1 2021 and held it in 1 quarter. The position peaked at $1.94M in Q1 2021. 75 funds tracked by Wall St. Rank hold ISLE as of Q2 2021.

  • UBS O'Connor reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q2 2021 after selling out during the quarter.
  • UBS O'Connor sold 200,000 Isleworth Healthcare Acquisition Corporation Common stock shares in Q2 2021, an estimated $1.94M.
  • UBS O'Connor first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q1 2021 and held it in 1 quarter.
  • UBS O'Connor's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $1.94M in Q1 2021.
  • 75 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q2 2021.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.